Juul's new high-tech vape can verify a user's age

Malaysia News News

Juul's new high-tech vape can verify a user's age
Malaysia Latest News,Malaysia Headlines
  • 📰 IntEngineering
  • ⏱ Reading Time:
  • 61 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 63%

The e-cigarette company is seeking FDA's approval after last year's ban.

Juul was previously banned because its PMTA lacked sufficient evidence regarding the toxicology of the products.reported that a 2019 federal survey found that one in every four high school goers in the US had used an e-cigarette in the previous 30 days.

The new product will also have a unique Pod ID chip to prevent the use of counterfeit cartridges. The e-cigarette will be Bluetooth-enabled with a larger, long-lasting battery and a “smart light system” that communicates battery life and e-liquid level to the user. Juul said it was seeking to sell tobacco-flavored pods at a nicotine concentration of less than 2%, as per a report byAlready launched in the UK, the press release said, “Initial behavioral research of the new platform in the UK has demonstrated compelling adoption and switching among adult smokers. Over 32% of JUUL2 System users have switched completely from combustible cigarettes 6 months after purchasing the product.

As Juul attempts to come back into the good books of the public with its new, high-tech e-cigarette, let’s not forget that it nearly went bankrupt after agreeing to pay $462 million in settlement to six states and Washington, DC, over claims of its devices causing addiction in minors, as per a report by“Our next-generation vapor platform PMTA is built on new technology that advances public-health objectives and compelling science that demonstrates a clear public-health benefit, as required to...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

IntEngineering /  🏆 287. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Juul Seeks FDA Approval for New Vape That Can Verify a User's AgeJuul Seeks FDA Approval for New Vape That Can Verify a User's AgeJuul is attempting a comeback with its next-generation vape after paying out a $462 million settlement to six states for its role in the teen vape epidemic.
Read more »

Juul seeks FDA approval for new vape product that can verify user ageJuul seeks FDA approval for new vape product that can verify user ageJuul, the leading e-cigarette brand in the United States, requested federal authorization from the Food and Drug Administration for a new vape product that can possibly address the agency's concerns with its vaping devices.
Read more »

Juul seeks US authorization for new e-cigaretteJuul seeks US authorization for new e-cigaretteJuul Labs said on Wednesday it was seeking U.S. authorization for a new e-cigarette that has age-verification capabilities and prevents the use of unauthorized refill cartridges.
Read more »

Juul seeks US authorization for new e-cigaretteJuul seeks US authorization for new e-cigaretteJuul Labs said on Wednesday it was seeking U.S. authorization for a new e-cigarette that has age-verification capabilities and prevents the use of unauthorized refill cartridges. The vaporizer, which has a unique Pod ID chip to prevent the use of counterfeit cartridges and an app to restrict underage access, is already on sale in Britain after its launch in 2021 as JUUL2 System.
Read more »

WSJ News Exclusive | Juul Has a New High-Tech Vape and Hopes the FDA Won’t Ban ItWSJ News Exclusive | Juul Has a New High-Tech Vape and Hopes the FDA Won’t Ban ItJuul Labs is seeking U.S. authorization for a next-generation vaporizer, while the e-cigarette maker waits for word on whether its current products can stay on the market
Read more »

FDA Approves New Drug to Prevent RSV in Babies and ToddlersFDA Approves New Drug to Prevent RSV in Babies and ToddlersThe US Food and Drug Administration approved a laboratory-made version of an antibody called nirsevimab which works to protect newborns from RSV.
Read more »



Render Time: 2025-08-31 00:04:44